Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Maria‐Luisa Schubert, Sascha Dietrich, Stephan Stilgenbauer, Anita Schmitt, Petra Pavel, Alexander Kunz, Andrea Bondong, Mandy Wegner, Peter Stadtherr, Susanne Jung, Anthony D. Ho, Carsten Müller‐Tidow, Michael Schmitt, Peter Dreger
Topics & Concepts
MedicineCytopeniaCytokine release syndromeChimeric antigen receptorLymphomaHematopoietic stem cell transplantationLeukapheresisTransplantationMantle cell lymphomaInternal medicineStem cellImmunologyOncologyGastroenterologyT cellCD34Bone marrowImmune systemBiologyGeneticsCAR-T cell therapy research